Skip to main content

Want a detailed portfolio tracker?

Generation Bio (GBIO) P/E (2020 - 2026)

Generation Bio (GBIO) P/E from Jun 30, 2020 to Feb 9, 2026. The TTM Generation Bio (GBIO) P/E is -0.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Generation Bio (GBIO)

YearP/EChange
2026-0.57-5.99%
2025-0.61+13.53%
2024-0.54-37.09%
2023-0.85-49.15%
2022-1.68-50.13%
2021-3.36-83.70%
2020-20.62N/A

Comparison Generation Bio (GBIO) P/E with competitors

Generation Bio (GBIO) P/E is -0.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.30%
NBYStablecoin Development Corp0.00-100.75%
ENLVEnlivex Ltd0.07-113.07%
FGENFibroGen Inc0.24-141.93%
CHRSCoherus Biosciences Inc0.85-248.21%
FBIOFortress Biotech Inc0.95-265.76%
ORMPOramed Pharmaceuticals Inc1.50-362.53%
AGENAgenus Inc3.01-625.67%
INVAInnoviva Inc3.15-650.90%
VXRTVaxart Inc3.55-720.01%
CRMDCorMedix Inc3.63-733.76%
CVACCureVac N.V.4.45-876.50%
GLPGGalapagos NV4.86-948.68%
SRPTSarepta Therapeutics Inc4.88-952.73%
ABEOAbeona Therapeutics Inc5.39-1041.01%
ABUSArbutus Biopharma Corp5.60-1077.36%
ZVRAZevra Therapeutics Inc5.89-1128.29%
SPROSpero Therapeutics Inc6.23-1187.89%
CGENCompugen Ltd6.31-1202.82%
RIGLRigel Pharmaceuticals6.87-1300.31%
SLXNSilexion Therapeutics Corp7.30-1374.37%
OMEROmeros Corporation9.26-1717.18%
AUPHAurinia Pharmaceuticals Inc9.58-1774.16%
PLXProtalix BioTherapeutics Inc10.89-2002.28%
ACADAcadia Pharmaceuticals Inc11.73-2148.57%
TBPHTheravance Biopharma Inc12.26-2241.77%
ADMAAdma Biologics Inc12.42-2269.02%
HRMYHarmony Biosciences Holdings Inc13.82-2513.91%
SABSSAB Biotherapeutics Inc14.14-2569.11%
NAGENiagen Bioscience Inc14.82-2688.21%
INCYIncyte Corp15.82-2863.65%
REGNRegeneron Pharmaceuticals Inc15.86-2869.61%
PBYIPuma Biotechnology Inc17.32-3124.46%
CPRXCatalyst Pharmaceuticals Inc17.44-3146.05%
EXELExelixis Inc17.54-3163.29%
TGTXTG Therapeutics Inc18.97-3412.72%
MDXGMimedx Group Inc20.55-3689.82%
XOMAXOMA Royalty Corp22.87-4095.53%
ARGXArgen X SE24.30-4344.14%
CTMXCytomX Therapeutics Inc24.82-4435.51%
XOMAOXOMA Royalty Corp25.34-4526.98%
HALOHalozyme Therapeutics Inc25.62-4575.70%
XOMAPXOMA Royalty Corp25.67-4583.80%
VRTXVertex Pharmaceuticals Inc27.99-4989.85%
RPRXRoyalty Pharma plc - Class A28.69-5110.86%
SLNOSoleno Therapeutics Inc29.02-5168.12%
ASNDAscendis Pharma A/S30.09-5355.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-6722.10%
APLSApellis Pharmaceuticals Inc39.02-6915.84%
BMRNBiomarin Pharmaceutical Inc42.21-7473.15%
KRYSKrystal Biotech Inc45.34-8020.15%
ONCBeiGene Ltd69.54-12246.65%
PHARPharming Group N.V.75.03-13204.74%
TECHBio-Techne Corp101.96-17909.10%
VCELVericel Corp109.92-19299.99%
ALNYAlnylam Pharmaceuticals Inc117.96-20705.00%
GMABGenmab140.29-24604.63%
TLXTelix Pharmaceuticals Ltd162.15-28423.29%
CORTCorcept Therapeutics Inc212.86-37279.89%